Axel Rominger

Lu-177-PSMA dosimetry for kidneys and tumors based on SPECT images at two imaging time points

A. Afshar-Oromieh, Gefei Chen, Zhonglin Lu, 2023, Frontiers in medicine.

PSMA-PET follow-up to assess response in patients not receiving PSMA therapy: Is there value beyond localization of disease?

A. Afshar-Oromieh, D. Kersting, T. Telli, 2024, Theranostics.

GRPR-targeting radiotheranostics for breast cancer management

Swantje Engelbrecht, Axel Rominger, Alice D’Onofrio, 2023, Frontiers in medicine.

Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2

A. Afshar-Oromieh, E. Moon, S. Imlimthan, 2024, Molecules.